SYK Stock Price & Analysis — Stryker Corporation (Healthcare >> Medical Devices)
SYK FAQ
What is SYK's P/E ratio?
Stryker Corporation (SYK) currently trades at a P/E ratio of 35.78.
What is SYK's ROE?
Stryker Corporation reports a Return on Equity (ROE) of 15.55%.
What is SYK's dividend yield?
Stryker Corporation offers a dividend yield of 0.98%.
What is SYK's Quality Score?
Our AI rates SYK's overall financial quality at 69 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy SYK?
Our AI Timing Score for SYK is 89 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does SYK belong to?
Stryker Corporation is classified under the Healthcare >> Medical Devices sector on the NYSE exchange
SYK AI Analysis Summary
Our AI summary for SYK: Stryker Corporation (NYSE), Healthcare >> Medical Devices sector. The stock currently trades at a P/E of 35.78, ROE of 15.55%, a dividend yield of 0.98%. Its financial Quality Score stands at 69/100 — mid-range fundamentals relative to the market. The AI Timing Score is 89/100 — multiple technical signals currently support price momentum. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 325.70
Price
-22.34
(-6.42%)
Day Change
|
|
|---|
SYK, the overall quality is ok ( Quality = 69) and the timing to buy is ...(Sign In to See)...
- Signal
- NEUTRAL
- Signal Description
- Company financial health is OK
- Reason
-
Acceleration of ROE growth rate is below our criteria.
ROA is too relatively low compare to ROE
Acceleration of ROA growth rate is below our criteria.
Acceleration of net profit margin growth rate is below our criteria
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not quite good , financial health is not quite good , and ability to make profit is good , ...
| Quality Factors |
|
51% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 99 |
| Magic Formula Rank by ROA |
1798
|
| Magic Formula Rank by ROE |
1798
|
| Magic Formula Rank by ROIC |
1909
|
| Price | 325.70 |
| PBV / Sector |
5.56 / -101.57
|
| Earning Per Share | 9.10 |
| PE / Sector |
35.78 / 31.23
|
| PEG or PE/Growth / Sector |
2.88 / 0.40
|
| Average 1M Daily Value |
708.21 M
|
| Average 1W Daily Value |
845.04 M
|
| Timing Factors |
|
42% |
| Financial Health |
|
58% |
| Ability to Make Profit |
|
72% |
| Return to Investors |
|
12% |
| Registration Details |
| Analyze Date | 2026-08-01 08:00:33 |
| Symbol | SYK |
| Name | STRYKER CORPORATION |
| Sector | Healthcare >> Medical Devices |
| Market | NYSE |
| Listed Shares | 383.36 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 133,424.88 / 20,104.97 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 1941 Stryker Way, Portage, MI, United States, 49002
Phone: (269) 385-2600
Website: https://www.stryker.com
Employees: 56,000
Sector: Healthcare >> Medical Devices
Description: Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, ankle, and trauma and extremities surgeries; and Mako Shoulder, which expands the smart robotics suite of applications. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 61 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.
Analyst Ratings & Target Price
ME vs SECTOR Healthcare >> Medical Devices
Click a bubble to view stock details · Bubble size represents market capitalization share
Google